Table 1.

Associations between ApoF expression and clinicopathological characteristics in 116 patients with HCC

Variable	No. of cases	ApoF expression		χ2 value	P-value
		Low (n = 40)	High (n = 76)
Age (years)
≤50	62	18	44	1.751	0.186
>50	54	22	32
Sex
Male	98	32	66	0.936	0.333
Female	18	8	10
HBsAg
Positive	71	24	47	0.037	0.847
Negative	45	16	29
AFP (ng/mL)
≤400	69	28	41	2.802	0.094
>400	47	12	35
Liver cirrhosis
Absent	36	6	30	7.3334	0.007
Present	80	34	46
Vascular invasion
Absent	88	31	57	0.089	0.765
Present	28	9	19
Tumor size
≤5 cm	82	29	53	0.097	0.756
>5 cm	34	11	23
Tumor number
Single	98	35	63	0.424	0.515
Multiple	18	5	13
Tumor differentiation
Well	33	13	20	0.492	0.483
Moderate–poor	83	27	56
BCLC stage
0/A	61	27	34	5.446	0.020
B/C	55	13	42
TNM stage
I/II	76	31	45	3.880	0.049
III/IV	40	9	31

AFP, alpha fetoprotein; BCLC, Barcelona Clinic Liver Cancer; TNM, tumor-node-metastasis; HBsAg, hepatitis B surface antigen.